DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,903,762 | +8.9% | 11,704 | +5.3% | 0.25% | +15.0% |
Q2 2023 | $2,666,880 | +3.3% | 11,112 | +8.5% | 0.22% | -6.4% |
Q1 2023 | $2,582,150 | -10.6% | 10,245 | -6.1% | 0.24% | -16.7% |
Q4 2022 | $2,889,751 | +6.2% | 10,913 | +3.6% | 0.28% | -0.7% |
Q3 2022 | $2,721,000 | +6.0% | 10,534 | +4.0% | 0.28% | +8.8% |
Q2 2022 | $2,567,000 | -11.8% | 10,129 | +2.1% | 0.26% | +2.8% |
Q1 2022 | $2,910,000 | +0.1% | 9,923 | +12.1% | 0.25% | +4.1% |
Q4 2021 | $2,908,000 | +31.6% | 8,848 | +21.9% | 0.24% | +19.0% |
Q3 2021 | $2,209,000 | +9.4% | 7,259 | -3.4% | 0.20% | +6.8% |
Q2 2021 | $2,019,000 | +16.2% | 7,518 | -2.5% | 0.19% | +11.0% |
Q1 2021 | $1,737,000 | +2.2% | 7,711 | +0.7% | 0.17% | -12.2% |
Q4 2020 | $1,700,000 | +4.9% | 7,660 | +1.7% | 0.20% | -8.8% |
Q3 2020 | $1,621,000 | +15.6% | 7,531 | -5.0% | 0.22% | +10.2% |
Q2 2020 | $1,402,000 | +30.3% | 7,928 | +2.1% | 0.20% | +7.7% |
Q1 2020 | $1,076,000 | +1.7% | 7,765 | +12.7% | 0.18% | +29.1% |
Q4 2019 | $1,058,000 | -10.9% | 6,891 | -16.3% | 0.14% | -19.4% |
Q3 2019 | $1,188,000 | -0.9% | 8,229 | -2.1% | 0.18% | -5.4% |
Q2 2019 | $1,199,000 | +7.6% | 8,402 | -0.4% | 0.18% | +6.3% |
Q1 2019 | $1,114,000 | +31.2% | 8,436 | +2.5% | 0.17% | +16.0% |
Q4 2018 | $849,000 | +15.8% | 8,233 | +21.9% | 0.15% | +31.6% |
Q3 2018 | $733,000 | +12.4% | 6,753 | +2.2% | 0.11% | +0.9% |
Q2 2018 | $652,000 | +9.6% | 6,607 | +8.8% | 0.11% | +3.7% |
Q1 2018 | $595,000 | +5.9% | 6,071 | -0.1% | 0.11% | +4.8% |
Q4 2017 | $562,000 | +18.3% | 6,077 | +10.2% | 0.10% | +10.6% |
Q3 2017 | $475,000 | -0.2% | 5,517 | -2.1% | 0.09% | -1.1% |
Q2 2017 | $476,000 | -18.9% | 5,638 | -17.7% | 0.10% | -20.2% |
Q1 2017 | $587,000 | +29.6% | 6,854 | +17.7% | 0.12% | +15.5% |
Q4 2016 | $453,000 | -3.4% | 5,824 | -2.3% | 0.10% | -3.7% |
Q3 2016 | $469,000 | -11.7% | 5,964 | +13.4% | 0.11% | -11.6% |
Q2 2016 | $531,000 | +55.3% | 5,258 | +45.9% | 0.12% | +40.7% |
Q1 2016 | $342,000 | +15.5% | 3,604 | +12.9% | 0.09% | +10.3% |
Q4 2015 | $296,000 | +0.3% | 3,193 | -7.8% | 0.08% | -6.0% |
Q3 2015 | $295,000 | +6.5% | 3,464 | +6.7% | 0.08% | +16.9% |
Q2 2015 | $277,000 | +4.1% | 3,248 | +3.7% | 0.07% | +6.0% |
Q1 2015 | $266,000 | -37.6% | 3,133 | -37.1% | 0.07% | -39.1% |
Q4 2014 | $426,000 | +54.9% | 4,980 | +36.4% | 0.11% | +48.6% |
Q3 2014 | $275,000 | -22.5% | 3,650 | -19.0% | 0.07% | -3.9% |
Q2 2014 | $355,000 | +63.6% | 4,505 | +55.4% | 0.08% | +54.0% |
Q1 2014 | $217,000 | -45.8% | 2,899 | -44.0% | 0.05% | -54.1% |
Q4 2013 | $400,000 | +22.0% | 5,175 | +9.1% | 0.11% | +11.2% |
Q3 2013 | $328,000 | +12.7% | 4,745 | +3.2% | 0.10% | +2.1% |
Q2 2013 | $291,000 | – | 4,597 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |